APA

Fisher B. J., Pugh S. L., Macdonald D. R., Chakravatri A., Lesser G. J., Fox S., Rogers C. L., Werner-Wasik M., Doyle T., Bahary J., Fiveash J. B., Bovi J. A., Howard S. P., Michael Yu H., D'Souza D., Laack N. N., Barani I. J., Kwok Y., Wahl D. R., Strasser J. F., Won M. & Mehta M. P. (20210215). Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. : International journal of radiation oncology, biology, physics.

Chicago

Fisher Barbara J, Pugh Stephanie L, Macdonald David R, Chakravatri Arnab, Lesser Glenn J, Fox Sherry, Rogers C Leland, Werner-Wasik Maria, Doyle Thomas, Bahary Jean-Paul, Fiveash John B, Bovi Joseph A, Howard Steven P, Michael Yu Hsiang-Hsuan, D'Souza David, Laack Nadia N, Barani Igor J, Kwok Young, Wahl Daniel R, Strasser Jon F, Won Minhee and Mehta Minesh P. 20210215. Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. : International journal of radiation oncology, biology, physics.

Harvard

Fisher B. J., Pugh S. L., Macdonald D. R., Chakravatri A., Lesser G. J., Fox S., Rogers C. L., Werner-Wasik M., Doyle T., Bahary J., Fiveash J. B., Bovi J. A., Howard S. P., Michael Yu H., D'Souza D., Laack N. N., Barani I. J., Kwok Y., Wahl D. R., Strasser J. F., Won M. and Mehta M. P. (20210215). Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. : International journal of radiation oncology, biology, physics.

MLA

Fisher Barbara J, Pugh Stephanie L, Macdonald David R, Chakravatri Arnab, Lesser Glenn J, Fox Sherry, Rogers C Leland, Werner-Wasik Maria, Doyle Thomas, Bahary Jean-Paul, Fiveash John B, Bovi Joseph A, Howard Steven P, Michael Yu Hsiang-Hsuan, D'Souza David, Laack Nadia N, Barani Igor J, Kwok Young, Wahl Daniel R, Strasser Jon F, Won Minhee and Mehta Minesh P. Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. : International journal of radiation oncology, biology, physics. 20210215.